QSAM Biosciences Return on Equity

QSAM Biosciences (QSAM) currently reports a ROE of -7.41%. That is below the Materials sector average of 19.1%. Use the charts on this page to explore QSAM Biosciences's ROE history and peer comparisons.

QSAM Biosciences's ROE of -7.41% is lower than the Materials sector average of 19.1%. That is roughly 3982.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but QSAM Biosciences's current -7.41% should be judged against Materials norms (sector average: 19.1%) and against QSAM's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of -7.41%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Materials average is 19.1%. From there, open related valuation or income-statement pages for QSAM Biosciences, and consider following QSAM for alerts when major investors trade the stock.

QSAM Biosciences is classified in the Materials sector. On ROE, it currently shows -7.41% versus a sector average near 19.1%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Materials are usually more informative than comparing QSAM with unrelated industries.